COMMUNIQUÉS West-GlobeNewswire

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

17/09/2024 - 14:30

Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 BRAINTREE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of [...]

INmune Bio Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints

17/09/2024 - 14:30

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, today announced that results of additional analysis of blinded [...]

Alkeus Pharmaceuticals Announces Results from the SAGA Study of Oral Gildeuretinol in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

17/09/2024 - 14:30

Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy (GA) lesion growth rate at 24 months, supporting further clinical development. Gildeuretinol showed a statistically significant [...]

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

16/09/2024 - 22:06

Innovative drug treatment developed in collaboration with SciSparc aims to enhance safety and efficacy in mental health and addiction care Vancouver, Canada, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( [...]

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

16/09/2024 - 22:06

This innovative drug combination treatment focuses on boosting safety and efficacy in mental health and addiction care TEL AVIV, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or " [...]

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16/09/2024 - 22:05

CARMEL, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide [...]

89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer

16/09/2024 - 22:05

SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of [...]

Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference

16/09/2024 - 22:05

REDWOOD CITY, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16/09/2024 - 22:01

BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, [...]

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

16/09/2024 - 22:01

BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]

Galapagos receives transparency notification from EcoR1 Capital

16/09/2024 - 22:01

Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian transparency [...]

ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium

16/09/2024 - 22:00

DALLAS, Sept. 16, 2024 (GLOBE NEWSWIRE) -- ImmuneSensor Therapeutics, a clinical-stage biotherapeutics company focused on the development of first- and best-in-class inhibitors and agonists targeting the cGAS-STING [...]

KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations

16/09/2024 - 21:06

RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) leads healthcare innovation, leveraging AI-driven patient management, remote diagnostics, and [...]

KFSHRC Deputy CEO Receives Global Innovative Healthcare & Impact Transformation Award at New York Summit

16/09/2024 - 20:06

RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive Officer Dr. Björn Zoéga has been awarded the prestigious 2024 C3 Global [...]

Sanofi: Information concerning the total number of voting rights and shares - August 2024

16/09/2024 - 18:44

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2024

16/09/2024 - 18:44

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Props.Cash Bolsters Responsible Gaming Offering with Birches Health Partnership

16/09/2024 - 17:20

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Leading sports gaming research platform Props.Cash is expanding its responsible gaming efforts by partnering with Birches Health, a national provider of gaming education [...]

Kairos Pharma Prices $6.2 Million Initial Public Offering

16/09/2024 - 16:49

Company anticipates commencement of trading on the NYSE American effective September 16, 2024 under the symbol “KAPA” LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

16/09/2024 - 16:47

Please see enclosed pdf. Attachment 16092024_trading_in_shares_KV